Allison C. Bischoff, Kristee Brown, Emily L. Lasse-Opsahl, Hannah R. Watkoske, Carlos E. Espinoza, Jude Ogechukwu. Okoye, Alberto C. Olivei, Leah M. Green, Ridesh Rai, Stephanie The, Wei Yan, Aaron D. denDekker, Eileen S. Carpenter, Jiaqi Shi, Filip Bednar, Timothy L. Frankel, Yaqing Zhang, Marina Pasca di Magliano
{"title":"表达Wilm 's Tumor 1的基质细胞促进胰腺癌生长","authors":"Allison C. Bischoff, Kristee Brown, Emily L. Lasse-Opsahl, Hannah R. Watkoske, Carlos E. Espinoza, Jude Ogechukwu. Okoye, Alberto C. Olivei, Leah M. Green, Ridesh Rai, Stephanie The, Wei Yan, Aaron D. denDekker, Eileen S. Carpenter, Jiaqi Shi, Filip Bednar, Timothy L. Frankel, Yaqing Zhang, Marina Pasca di Magliano","doi":"10.1158/1538-7445.pancreatic25-a066","DOIUrl":null,"url":null,"abstract":"Cancer associated fibroblasts (CAFs) are a prevalent cell population in the microenvironment of pancreatic cancer. The contribution of cell of origin to CAF heterogeneity is still incompletely understood. Expression of the transcription factor Wilm’s Tumor 1 (Wt1) marks mesothelial cells, as well as a transcriptionally distinct population of fibroblasts in the normal pancreas. WT1/Wt1 expression also defines a population of CAFs in both human and mouse pancreatic cancer. We employed a previously described tamoxifen-inducible model of lineage tracing wherein cells expressing Wt1 and their progeny are labelled with tdTomato. To determine the functional role of these cells, we generated a diphtheria-toxin inducible model to deplete Wt1-expressing cells in orthotopic tumors. By lineage tracing, we found that Wt1 + cells expand in pancreatic cancer, where they give rise to a population of inflammatory pSTAT3+ CAFs. Depletion of Wt1 +stromal cells resulted in smaller tumors with decreased pSTAT3+ cells. Contrary to our expectations, these tumors also had increased immunosuppressive macrophage activation and reduced infiltration of CD8+ and FOXP3+ T cells. Notably, the reduction in tumor weights observed with Wt1 + cell depletion was independent of CD8+ and CD4+ T cells. Instead,Wt1 + cancer-associated fibroblasts expressed high levels of known tumor-promoting ligands that likely interact directly with the tumor epithelium to drive progression. Accordingly, Wt1-expressing cell-depleted tumors had reduced epithelial MAPK activation. In vitro analyses also demonstrated the ability of fibroblast-conditioned media to augment epithelial, KRAS-dependent MAPK activation. Together, our data show that Wt1 + stromal cells represent a tumor-promoting CAF population; while this population might constitute a potential therapeutic target, caution will be needed to avoid exacerbating immune suppression. Citation Format: Allison C. Bischoff, Kristee Brown, Emily L. Lasse-Opsahl, Hannah R. Watkoske, Carlos E. Espinoza, Jude Ogechukwu. Okoye, Alberto C. Olivei, Leah M. Green, Ridesh Rai, Stephanie The, Wei Yan, Aaron D. denDekker, Eileen S. Carpenter, Jiaqi Shi, Filip Bednar, Timothy L. Frankel, Yaqing Zhang, Marina Pasca di Magliano. Wilm’s Tumor 1-Expressing Stromal Cells Promote Pancreatic Cancer Growth [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Advances in Pancreatic Cancer Research—Emerging Science Driving Transformative Solutions; Boston, MA; 2025 Sep 28-Oct 1; Boston, MA. Philadelphia (PA): AACR; Cancer Res 2025;85(18_Suppl_3): nr A066.","PeriodicalId":9441,"journal":{"name":"Cancer research","volume":"21 1","pages":""},"PeriodicalIF":16.6000,"publicationDate":"2025-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Abstract A066: Wilm’s Tumor 1-Expressing Stromal Cells Promote Pancreatic Cancer Growth\",\"authors\":\"Allison C. Bischoff, Kristee Brown, Emily L. Lasse-Opsahl, Hannah R. Watkoske, Carlos E. Espinoza, Jude Ogechukwu. Okoye, Alberto C. Olivei, Leah M. Green, Ridesh Rai, Stephanie The, Wei Yan, Aaron D. denDekker, Eileen S. Carpenter, Jiaqi Shi, Filip Bednar, Timothy L. Frankel, Yaqing Zhang, Marina Pasca di Magliano\",\"doi\":\"10.1158/1538-7445.pancreatic25-a066\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Cancer associated fibroblasts (CAFs) are a prevalent cell population in the microenvironment of pancreatic cancer. The contribution of cell of origin to CAF heterogeneity is still incompletely understood. Expression of the transcription factor Wilm’s Tumor 1 (Wt1) marks mesothelial cells, as well as a transcriptionally distinct population of fibroblasts in the normal pancreas. WT1/Wt1 expression also defines a population of CAFs in both human and mouse pancreatic cancer. We employed a previously described tamoxifen-inducible model of lineage tracing wherein cells expressing Wt1 and their progeny are labelled with tdTomato. To determine the functional role of these cells, we generated a diphtheria-toxin inducible model to deplete Wt1-expressing cells in orthotopic tumors. By lineage tracing, we found that Wt1 + cells expand in pancreatic cancer, where they give rise to a population of inflammatory pSTAT3+ CAFs. Depletion of Wt1 +stromal cells resulted in smaller tumors with decreased pSTAT3+ cells. Contrary to our expectations, these tumors also had increased immunosuppressive macrophage activation and reduced infiltration of CD8+ and FOXP3+ T cells. Notably, the reduction in tumor weights observed with Wt1 + cell depletion was independent of CD8+ and CD4+ T cells. Instead,Wt1 + cancer-associated fibroblasts expressed high levels of known tumor-promoting ligands that likely interact directly with the tumor epithelium to drive progression. Accordingly, Wt1-expressing cell-depleted tumors had reduced epithelial MAPK activation. In vitro analyses also demonstrated the ability of fibroblast-conditioned media to augment epithelial, KRAS-dependent MAPK activation. Together, our data show that Wt1 + stromal cells represent a tumor-promoting CAF population; while this population might constitute a potential therapeutic target, caution will be needed to avoid exacerbating immune suppression. Citation Format: Allison C. Bischoff, Kristee Brown, Emily L. Lasse-Opsahl, Hannah R. Watkoske, Carlos E. Espinoza, Jude Ogechukwu. Okoye, Alberto C. Olivei, Leah M. Green, Ridesh Rai, Stephanie The, Wei Yan, Aaron D. denDekker, Eileen S. Carpenter, Jiaqi Shi, Filip Bednar, Timothy L. Frankel, Yaqing Zhang, Marina Pasca di Magliano. Wilm’s Tumor 1-Expressing Stromal Cells Promote Pancreatic Cancer Growth [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Advances in Pancreatic Cancer Research—Emerging Science Driving Transformative Solutions; Boston, MA; 2025 Sep 28-Oct 1; Boston, MA. Philadelphia (PA): AACR; Cancer Res 2025;85(18_Suppl_3): nr A066.\",\"PeriodicalId\":9441,\"journal\":{\"name\":\"Cancer research\",\"volume\":\"21 1\",\"pages\":\"\"},\"PeriodicalIF\":16.6000,\"publicationDate\":\"2025-09-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1158/1538-7445.pancreatic25-a066\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1158/1538-7445.pancreatic25-a066","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
癌症相关成纤维细胞(CAFs)是胰腺癌微环境中普遍存在的细胞群。细胞起源对CAF异质性的贡献仍不完全清楚。转录因子Wilm肿瘤1 (Wt1)的表达标志着间皮细胞,以及正常胰腺中转录不同的成纤维细胞群。WT1/ WT1的表达也定义了人类和小鼠胰腺癌中的cas群体。我们采用了先前描述的他莫昔芬诱导的谱系追踪模型,其中表达Wt1的细胞及其后代被标记为tdTomato。为了确定这些细胞的功能作用,我们建立了白喉毒素诱导模型,以消耗原位肿瘤中表达wt1的细胞。通过谱系追踪,我们发现Wt1 +细胞在胰腺癌中扩展,在那里它们产生炎症性pSTAT3+ CAFs群体。Wt1 +基质细胞的缺失导致肿瘤变小,pSTAT3+细胞减少。与我们的预期相反,这些肿瘤还增加了免疫抑制性巨噬细胞激活,减少了CD8+和FOXP3+ T细胞的浸润。值得注意的是,Wt1 +细胞消耗观察到的肿瘤重量减少与CD8+和CD4+ T细胞无关。相反,Wt1 +癌症相关成纤维细胞表达高水平的已知肿瘤促进配体,这些配体可能直接与肿瘤上皮相互作用以驱动进展。因此,表达wt1的细胞枯竭肿瘤降低了上皮MAPK的激活。体外分析也证明了成纤维细胞条件培养基增强上皮、kras依赖性MAPK激活的能力。总之,我们的数据表明Wt1 +基质细胞代表了促进肿瘤的CAF群体;虽然这一人群可能构成潜在的治疗目标,但需要谨慎避免加剧免疫抑制。引文格式:Allison C. Bischoff, Kristee Brown, Emily L. lase - opsahl, Hannah R. Watkoske, Carlos E. Espinoza, Jude Ogechukwu。Okoye, Alberto C. Olivei, Leah M. Green, Ridesh Rai, Stephanie The,闫伟,Aaron D. denDekker, Eileen S. Carpenter,石佳琪,philip Bednar, Timothy L. Frankel,张亚青,Marina Pasca di Magliano。表达Wilm 's Tumor 1的基质细胞促进胰腺癌生长[摘要]。摘自:AACR癌症研究特别会议论文集:胰腺癌研究进展-新兴科学驱动变革解决方案;波士顿;2025年9月28日至10月1日;波士顿,MA。费城(PA): AACR;癌症研究2025;85(18_Suppl_3): nr A066。
Cancer associated fibroblasts (CAFs) are a prevalent cell population in the microenvironment of pancreatic cancer. The contribution of cell of origin to CAF heterogeneity is still incompletely understood. Expression of the transcription factor Wilm’s Tumor 1 (Wt1) marks mesothelial cells, as well as a transcriptionally distinct population of fibroblasts in the normal pancreas. WT1/Wt1 expression also defines a population of CAFs in both human and mouse pancreatic cancer. We employed a previously described tamoxifen-inducible model of lineage tracing wherein cells expressing Wt1 and their progeny are labelled with tdTomato. To determine the functional role of these cells, we generated a diphtheria-toxin inducible model to deplete Wt1-expressing cells in orthotopic tumors. By lineage tracing, we found that Wt1 + cells expand in pancreatic cancer, where they give rise to a population of inflammatory pSTAT3+ CAFs. Depletion of Wt1 +stromal cells resulted in smaller tumors with decreased pSTAT3+ cells. Contrary to our expectations, these tumors also had increased immunosuppressive macrophage activation and reduced infiltration of CD8+ and FOXP3+ T cells. Notably, the reduction in tumor weights observed with Wt1 + cell depletion was independent of CD8+ and CD4+ T cells. Instead,Wt1 + cancer-associated fibroblasts expressed high levels of known tumor-promoting ligands that likely interact directly with the tumor epithelium to drive progression. Accordingly, Wt1-expressing cell-depleted tumors had reduced epithelial MAPK activation. In vitro analyses also demonstrated the ability of fibroblast-conditioned media to augment epithelial, KRAS-dependent MAPK activation. Together, our data show that Wt1 + stromal cells represent a tumor-promoting CAF population; while this population might constitute a potential therapeutic target, caution will be needed to avoid exacerbating immune suppression. Citation Format: Allison C. Bischoff, Kristee Brown, Emily L. Lasse-Opsahl, Hannah R. Watkoske, Carlos E. Espinoza, Jude Ogechukwu. Okoye, Alberto C. Olivei, Leah M. Green, Ridesh Rai, Stephanie The, Wei Yan, Aaron D. denDekker, Eileen S. Carpenter, Jiaqi Shi, Filip Bednar, Timothy L. Frankel, Yaqing Zhang, Marina Pasca di Magliano. Wilm’s Tumor 1-Expressing Stromal Cells Promote Pancreatic Cancer Growth [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Advances in Pancreatic Cancer Research—Emerging Science Driving Transformative Solutions; Boston, MA; 2025 Sep 28-Oct 1; Boston, MA. Philadelphia (PA): AACR; Cancer Res 2025;85(18_Suppl_3): nr A066.
期刊介绍:
Cancer Research, published by the American Association for Cancer Research (AACR), is a journal that focuses on impactful original studies, reviews, and opinion pieces relevant to the broad cancer research community. Manuscripts that present conceptual or technological advances leading to insights into cancer biology are particularly sought after. The journal also places emphasis on convergence science, which involves bridging multiple distinct areas of cancer research.
With primary subsections including Cancer Biology, Cancer Immunology, Cancer Metabolism and Molecular Mechanisms, Translational Cancer Biology, Cancer Landscapes, and Convergence Science, Cancer Research has a comprehensive scope. It is published twice a month and has one volume per year, with a print ISSN of 0008-5472 and an online ISSN of 1538-7445.
Cancer Research is abstracted and/or indexed in various databases and platforms, including BIOSIS Previews (R) Database, MEDLINE, Current Contents/Life Sciences, Current Contents/Clinical Medicine, Science Citation Index, Scopus, and Web of Science.